Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bio-Techne (NASDAQ:TECH – Get Rating) had its target price raised by Robert W. Baird from $99.00 to $100.00 in a report released on Thursday, The Fly reports. Several other research firms also recently weighed in on TECH. Wells Fargo & Company raised Bio-Techne from an underweight rating to an equal weight rating and set a […]
Montanaro Asset Management Ltd raised its position in Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 280.4% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 387,800 shares of the biotechnology company’s stock after purchasing an additional 285,850 shares during the quarter. Bio-Techne accounts for […]
Bio-Techne (NASDAQ:TECH – Get Rating) released its quarterly earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. The company had revenue of $294.15 million for the quarter, compared to analyst estimates of $298.55 million. Bio-Techne had a net margin of 24.15% […]
Bio-Techne (NASDAQ:TECH – Get Rating) posted its earnings results on Wednesday. The biotechnology company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a return on equity of 15.31% and a net margin of 24.15%. The firm had revenue of $294.15 million during the quarter, compared […]
Bio-Techne (NASDAQ:TECH – Get Rating) issued its earnings results on Wednesday. The biotechnology company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.05, Briefing.com reports. Bio-Techne had a net margin of 24.15% and a return on equity of 15.31%. The business had revenue of $294.15 million during […]